Scarica l'app Stockscreener
9.16
0.00%
0.00
Dopo l'orario di chiusura:
9.16
Precedente Chiudi:
$9.16
Aprire:
$9.19
Volume 24 ore:
207.17K
Relative Volume:
0.84
Capitalizzazione di mercato:
$2.83B
Reddito:
$391.87M
Utile/perdita netta:
$-441.45M
Rapporto P/E:
-4.9514
EPS:
-1.85
Flusso di cassa netto:
$-301.21M
1 W Prestazione:
+4.93%
1M Prestazione:
-0.65%
6M Prestazione:
-29.48%
1 anno Prestazione:
-21.03%
Intervallo 1D:
$9.035
$9.20
Intervallo di 1 settimana:
$8.51
$9.20
Portata 52W:
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
Confronta ALVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
9.16 | 2.83B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
152.82 | 68.32B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.66 | 46.55B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.85 | 43.80B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.33 | 19.01B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
306.41 | 13.79B | 2.99B | 1.21B | 1.13B | 25.06 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | UBS | Buy |
| 2024-01-29 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-09-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-07 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Downgrade | Citigroup | Buy → Sell |
| 2022-07-26 | Iniziato | Citigroup | Buy |
Mostra tutto
Alvotech Borsa (ALVO) Ultime notizie
Does Alvotech stock pay reliable dividendsMarket-leading growth rates - jammulinksnews.com
What risks could impact Alvotech stock performanceHigh-octane gains - jammulinksnews.com
What analysts say about Alvotech stockExceptional profit potential - Autocar Professional
Can Alvotech stock recover from recent declineOutstanding trading profits - jammulinksnews.com
Wall Street Analysts See a 91.05% Upside in Alvotech (ALVO): Can the Stock Really Move This High? - Yahoo Finance
Dr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License Agreement - Insider Monkey
Alvotech Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com
Alvotech Equity Warrant Stock Analysis and ForecastPhenomenal returns - jammulinksnews.com
What analysts say about Alvotech Equity Warrant stockFastest-growing stock picks - jammulinksnews.com
What drives Alvotech Equity Warrant stock priceRapidly expanding wealth - jammulinksnews.com
What drives Alvotech stock priceSuperior capital gains - Autocar Professional
Is Alvotech Equity Warrant a good long term investmentAccelerated financial growth - Autocar Professional
Is Alvotech a good long term investmentAccelerated wealth building - jammulinksnews.com
Alvotech (ALVO) Stock Analysis: Unlocking a Potential 107% Upside with Biosimilar Innovations - DirectorsTalk Interviews
UBS Group Lowers Alvotech (NASDAQ:ALVO) Price Target to $14.00 - MarketBeat
UBS Expects Alvotech To Bounce Back After Second-Quarter Dip - Finimize
UBS Says Alvotech Set for H2 Growth on Pipeline Launches, Private Label Deal - MarketScreener
How high can Alvotech stock price go in 2025Free Signals Group - beatles.ru
Alvotech names veteran Linda Jónsdóttir finance chief - MSN
Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group - MSN
Alvotech Azioni (ALVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.25%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):